Hunan Warrant Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hunan Warrant Pharmaceutical Co., Ltd.

Why is Hunan Warrant Pharmaceutical Co., Ltd. ?

With ROE of 5.51%, it has a expensive valuation with a 4.04 Price to Book Value

Over the past year, while the stock has generated a return of 39.63%, its profits have fallen by -46.4%
At the current price, the company has a high dividend yield of 0.2

Market Beating Performance

The stock has generated a return of 39.63% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hunan Warrant Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Hunan Warrant Pharmaceutical Co., Ltd.

0.95%

0.54

64.12%

China Shanghai Composite

21.74%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.78%

EBIT Growth (5y)

-2.62%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.08

Sales to Capital Employed (avg)

0.69

Tax Ratio

11.03%

Dividend Payout Ratio

10.03%

Pledged Shares

Institutional Holding

ROCE (avg)

16.36%

ROE (avg)

12.38%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.79

EV to EBIT

42.15

EV to EBITDA

32.62

EV to Capital Employed

2.79

EV to Sales

3.76

PEG Ratio

Dividend Yield

0.21%

ROCE (Latest)

6.61%

ROE (Latest)

11.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 348.11 MM

NET PROFIT(9M)

Higher at CNY 194.04 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.57 times

-24What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 22.37 %

INTEREST COVERAGE RATIO(Q)

Lowest at 2,601.41

RAW MATERIAL COST(Y)

Grown by 6.36% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.35 times

NET SALES(Q)

Lowest at CNY 324.55 MM

INTEREST(Q)

Highest at CNY 1.17 MM

OPERATING PROFIT(Q)

Lowest at CNY 30.34 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.35 %

NET PROFIT(Q)

Lowest at CNY 26.88 MM

Here's what is working for Hunan Warrant Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 348.11 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Highest at 1.57 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Hunan Warrant Pharmaceutical Co., Ltd.

Interest

At CNY 1.17 MM has Grown at 80.15%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 2,601.41

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at 22.37 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales

Lowest at CNY 324.55 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Interest

Highest at CNY 1.17 MM

in the last five periods and Increased by 80.15% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY 30.34 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 9.35 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

Lowest at CNY 26.88 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Profit

Fallen at -34.79%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Debtors Turnover Ratio

Lowest at 5.35 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 6.36% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales